CQ Medical Acquires Bionix Radiation Therapy Unit
Slice of Healthcare Team
12/02/2025
Key highlights
- Strengthens CQ Medical's product portfolio
- Bionix maintains independent Ambulatory Care unit
- Continues commitment to quality and innovation
- Transition ensures seamless customer support
Source: PR Newswire
Notable Quotes
“ The Bionix radiation therapy acquisition brings several complementary product lines to CQ Medical, as well as adding a strong commercial team from the Bionix organization. ”
Michael Galbus, CEO at CQ Medical
“ CQ Medical is deeply respected in the radiation oncology market, and we are confident they are the right partner to continue supporting the radiotherapy customers with the highest level of innovation, service, and product quality. ”
Chris Becker, President and CEO at Bionix
Why this matters
This acquisition enhances CQ Medical's capabilities in radiation therapy, expanding its innovative offerings and ensuring better patient outcomes. It also allows Bionix to concentrate on its Ambulatory Care services, promoting specialized care in multiple healthcare segments. This development is particularly significant for the healthcare sector.
Expert Insights
Share Your Expert Insights
Have relevant experience or professional perspective? Add your thoughtful insights to this article.
